Nishank Jain

1.2k total citations
36 papers, 824 citations indexed

About

Nishank Jain is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Internal Medicine. According to data from OpenAlex, Nishank Jain has authored 36 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 10 papers in Nephrology and 7 papers in Internal Medicine. Recurrent topics in Nishank Jain's work include Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Dialysis and Renal Disease Management (7 papers). Nishank Jain is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Dialysis and Renal Disease Management (7 papers). Nishank Jain collaborates with scholars based in United States, Singapore and India. Nishank Jain's co-authors include Robert F. Reilly, S. Susan Hedayati, Subhash Banerjee, Bertis B. Little, Robert F. Reilly, Rick Weideman, Emmanouil S. Brilakis, A. John Rush, Thomas Carmody and Madhukar H. Trivedi and has published in prestigious journals such as JAMA, American Journal of Clinical Nutrition and Kidney International.

In The Last Decade

Nishank Jain

36 papers receiving 807 citations

Peers

Nishank Jain
Lucas Lauder Germany
C. Collin France
Bruno Riou France
Narut Prasitlumkum United States
Gail Makos United States
Ahmet Toprak Türkiye
A. Ahsan Ejaz United States
Lucas Lauder Germany
Nishank Jain
Citations per year, relative to Nishank Jain Nishank Jain (= 1×) peers Lucas Lauder

Countries citing papers authored by Nishank Jain

Since Specialization
Citations

This map shows the geographic impact of Nishank Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nishank Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nishank Jain more than expected).

Fields of papers citing papers by Nishank Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nishank Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nishank Jain. The network helps show where Nishank Jain may publish in the future.

Co-authorship network of co-authors of Nishank Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Nishank Jain. A scholar is included among the top collaborators of Nishank Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nishank Jain. Nishank Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Amudha, Vignesh Chidambaram, Marie Gilbert Majella, et al.. (2024). Renal Biomarkers in Heart Failure. JACC Advances. 3(2). 100765–100765. 2 indexed citations
2.
Corken, Adam, Rajshekhar A. Kore, Oleg Karaduta, et al.. (2024). Platelets, inflammation, and purinergic receptors in chronic kidney disease. Kidney International. 106(3). 392–399. 7 indexed citations
3.
Kore, Rajshekhar A., Alexandra M. Moore, Jerry Ware, et al.. (2023). Platelet Count and Platelet Volume in Patients with CKD. Journal of the American Society of Nephrology. 34(11). 1772–1775. 1 indexed citations
4.
Jain, Nishank, Adam Corken, John M. Arthur, et al.. (2023). Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease. Vascular Pharmacology. 148. 107143–107143. 8 indexed citations
5.
Corken, Adam, Jerry Ware, Junqiang Dai, et al.. (2022). Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study. Kidney360. 3(12). 2036–2047. 9 indexed citations
6.
Jain, Nishank, Milind A. Phadnis, Suzanne Hunt, et al.. (2021). Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis. Kidney International Reports. 6(9). 2381–2391. 6 indexed citations
7.
Jain, Nishank, Fei Wan, Monica T. Kothari, et al.. (2019). Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial. BMC Nephrology. 20(1). 395–395. 12 indexed citations
8.
Gregg, L. Parker, Nishank Jain, Thomas Carmody, et al.. (2019). Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes. American Journal of Nephrology. 50(1). 37–47. 36 indexed citations
9.
Singh, Manisha, Deepa Raghavan, James S. Williams, et al.. (2018). Prevalence of Chronic Kidney Disease, Thrombotic Cardiovascular Events, and Use of Oral P2Y<sub>12</sub> Inhibitors among Veterans. American Journal of Nephrology. 47(2). 67–71. 7 indexed citations
10.
Jain, Nishank & Robert F. Reilly. (2017). Hungry bone syndrome. Current Opinion in Nephrology & Hypertension. 26(4). 250–255. 81 indexed citations
11.
Hedayati, S. Susan, L. Parker Gregg, Thomas Carmody, et al.. (2017). Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence. JAMA. 318(19). 1876–1876. 72 indexed citations
12.
McGreal, Kerri, Pooja Budhiraja, Nishank Jain, & Alan S.L. Yu. (2016). Current Challenges in the Evaluation and Management of Hyponatremia. Kidney Diseases. 2(2). 56–63. 10 indexed citations
13.
Jain, Nishank, Xilong Li, Beverley Adams‐Huet, et al.. (2015). Differences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients With Versus Without Chronic Kidney Disease. The American Journal of Cardiology. 117(4). 656–663. 18 indexed citations
14.
Jain, Nishank & Robert F. Reilly. (2014). Effects of dietary interventions on incidence and progression of CKD. Nature Reviews Nephrology. 10(12). 712–724. 46 indexed citations
15.
Jain, Nishank, Abu Minhajuddin, Ian J. Neeland, et al.. (2014). Association of urinary sodium-to-potassium ratio with obesity in a multiethnic cohort. American Journal of Clinical Nutrition. 99(5). 992–998. 37 indexed citations
16.
Jain, Nishank & Essam F. Elsayed. (2013). Dietary phosphate: what do we know about its toxicity. Journal of Nephrology. 26(5). 856–864. 16 indexed citations
17.
Jain, Nishank & Robert F. Reilly. (2012). Filling in the gap. Nature Reviews Nephrology. 8(10). 562–563. 1 indexed citations
18.
Jain, Nishank, Bertis B. Little, Rick Weideman, et al.. (2012). Predictors of Hyperkalemia and Death in Patients With Cardiac and Renal Disease. The American Journal of Cardiology. 109(10). 1510–1513. 173 indexed citations
19.
Jain, Nishank, Madhukar H. Trivedi, A. John Rush, et al.. (2012). Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST). Contemporary Clinical Trials. 34(1). 136–144. 17 indexed citations
20.
Jain, Nishank & S. Susan Hedayati. (2011). How should clinicians interpret cardiac troponin values in patients with ESRD?. Seminars in Dialysis. 24(4). 398–400. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026